Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
23-4
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
23-4
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #35916
advertisement
Tang X
15
Showing records 1 to 15 |
Display all abstracts from
Tang X
108476
Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
Bai X
Investigative Ophthalmology and Visual Science
2023; 64: 31
107921
A triple crosslinked micelle-hydrogel lacrimal implant for localized and prolonged therapy of glaucoma
Zhao J
European Journal of Pharmaceutics and Biopharmaceutics
2023; 185: 44-54
108476
Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
Ye D
Investigative Ophthalmology and Visual Science
2023; 64: 31
107921
A triple crosslinked micelle-hydrogel lacrimal implant for localized and prolonged therapy of glaucoma
Xiong J; Ning Y
European Journal of Pharmaceutics and Biopharmaceutics
2023; 185: 44-54
108476
Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
Shi Y; Fan M
Investigative Ophthalmology and Visual Science
2023; 64: 31
107921
A triple crosslinked micelle-hydrogel lacrimal implant for localized and prolonged therapy of glaucoma
Wang Z
European Journal of Pharmaceutics and Biopharmaceutics
2023; 185: 44-54
108476
Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
Lu P; Feng Y
Investigative Ophthalmology and Visual Science
2023; 64: 31
107921
A triple crosslinked micelle-hydrogel lacrimal implant for localized and prolonged therapy of glaucoma
Long L
European Journal of Pharmaceutics and Biopharmaceutics
2023; 185: 44-54
108476
Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
Hu C
Investigative Ophthalmology and Visual Science
2023; 64: 31
107921
A triple crosslinked micelle-hydrogel lacrimal implant for localized and prolonged therapy of glaucoma
He H
European Journal of Pharmaceutics and Biopharmaceutics
2023; 185: 44-54
108476
Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
Liao J
Investigative Ophthalmology and Visual Science
2023; 64: 31
107921
A triple crosslinked micelle-hydrogel lacrimal implant for localized and prolonged therapy of glaucoma
Gou J; Yin T
European Journal of Pharmaceutics and Biopharmaceutics
2023; 185: 44-54
108476
Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
Cui K; Tang X
Investigative Ophthalmology and Visual Science
2023; 64: 31
107921
A triple crosslinked micelle-hydrogel lacrimal implant for localized and prolonged therapy of glaucoma
Tang X; Zhang Y
European Journal of Pharmaceutics and Biopharmaceutics
2023; 185: 44-54
108476
Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
Wu P; Xu F; Xu Y; Huang J
Investigative Ophthalmology and Visual Science
2023; 64: 31
Issue
23-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept